| Literature DB >> 36139047 |
Adriane Dâmares de Sousa Jorge Batalha1, Damy Caroline de Melo Souza1, Rosmery Duran Ubiera1, Francisco Celio Maia Chaves2, Wuelton Marcelo Monteiro3,4, Felipe Moura Araújo da Silva5, Hector Henrique Ferreira Koolen3,6, Antônio Luiz Boechat1,7, Marco Aurélio Sartim1,3,8.
Abstract
Plants of the species Fridericia chica (Bonpl.) L. G. Lohmann (Bignoniaceae), which are widely distributed in Brazil and named crajiru in the state of Amazonas, are known in folk medicine as a traditional medicine in the form of a tea for the treatment of intestinal colic, diarrhea, and anemia, among other diseases. The chemical analysis of extracts of the leaves has identified phenolic compounds, a class of secondary metabolites that provide defense for plants and benefits to the health of humans. Several studies have shown the therapeutic efficacy of F. chica extracts, with antitumor, antiviral, wound healing, anti-inflammatory, and antioxidant activities being among the therapeutic applications already proven. The healing action of F. chica leaf extract has been demonstrated in several experimental models, and shows the ability to favor the proliferation of fibroblasts, which is essential for tissue repair. The anti-inflammatory activity of F. chica has been clearly demonstrated by several authors, who suggest that it is related to the presence of 3-deoxyanthocyanidins, which is capable of inhibiting pro-inflammatory pathways such as the kappa B (NF-kB) nuclear transcription factor pathway. Another important effect attributed to this species is the antioxidant effect, attributed to phenolic compounds interrupting chain reactions caused by free radicals and donating hydrogen atoms or electrons. In conclusion, the species Fridericia chica has great therapeutic potential, which is detailed in this paper with the objective of encouraging new research and promoting the sum of efforts for the inclusion of herbal medicines in health systems around the world.Entities:
Keywords: Fridericia chica; anti-inflammatory; antioxidant; phytochemistry; wound healing
Mesh:
Substances:
Year: 2022 PMID: 36139047 PMCID: PMC9496332 DOI: 10.3390/biom12091208
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1Fridericia chica (Bonpl.) L. G. Lohmann: specimen and presentations forms. (A) Arboreal specimen of adult F. chica in situ in the city of Manaus, Amazonas Brazil. (B) Dried leaves of F. chica as marketed in the city of Manaus, Brazil. (C) Tea obtained from the dried leaves of F. chica and its main compounds responsible for the characteristic color. Photos: Author.
Figure 2Polyphenols (1–31) of F. chica.
Phytochemical components of F. chica extracts and their biological activities.
| Compound No. | Name | Source | Isolation/Detection | Biological Activity * |
|---|---|---|---|---|
|
| ||||
|
| Carajurin | leaves, MeOH | Isolation [ | Anti-inflammatory [ |
|
| Carajurone | leaves, MeOH | Isolation [ | N.A. |
|
| 3’-Hydroxy-carajurone | leaves, MeOH | Isolation [ | N.A. |
|
| 3’-Hydroxy-carajurin | leaves, MeOH | Isolation [ | N.A. |
|
| 6,7,3’,4’-Tetrahydroxy-5-methoxyflavylium | leaves, DCM fraction | Isolation [ | N.A. |
|
| 6,7,4’-Trihydroxy-5-methoxyflavylium | leaves, DCM fraction | Isolation [ | N.A. |
|
| ||||
|
| Carajuflavone | leaves, AcOEt fraction | Isolation [ | N.A. |
|
| Luteolin | leaves, AcOEt fraction | Isolation [ | Anti-inflammatory [ |
|
| Chrysoeriol | leaves, 70% EtOH | HPLC-MS detection | Anti-inflammatory [ |
|
| 4′-Hydroxy-3,7-dimethoxyflavone | leaves, EtOH | Isolation [ | N.A. |
|
| 5,7-dimethoxy-4′-hydroxyflavone | leaves, 70% EtOH | HPLC-MS detection | N.A. |
|
| Acacetin | leaves, MeOH | Isolation [ | Anti-inflammatory [ |
|
| Isoscutellarein | leaves, 90% EtOH | HPLC-MS detection | Antioxidant [ |
|
| Scutellarein | leaves, 90% EtOH | HPLC-MS detection, isolation [ | Anti-inflammatory [ |
|
| 6-Hydroxyluteolin | leaves, 90% EtOH | HPLC-MS detection | N.A. |
|
| Hispidulin | leaves, 90% EtOH | HPLC-MS detection | Anti-inflammatory [ |
|
| Apigenin | leaves, 90% EtOH | HPLC-MS detection, isolation [ | Anti-inflammatory [ |
|
| Thevetiaflavone | leaves, AcOEt fraction | Isolation [ | Antioxidant [ |
|
| Cirsimarin | leaves, 70% EtOH | HPLC-MS detection | Anti-inflammatory [ |
|
| Apigenin 7-glucuronide | leaves, 80% MeOH | HPLC-MS detection | Anti-inflammatory [ |
|
| Scutellarin | leaves, 80% MeOH | HPLC-MS detection | Anti-inflammatory [ |
|
| Chrysoeriol- | leaves, 70% EtOH | HPLC-MS detection | N.A. |
|
| ||||
|
| Quercetin- | leaves, 70% EtOH | HPLC-MS detection | N.A. |
|
| Kaempferol | leaves, 70% EtOH | HPLC-MS detection | Anti-inflammatory [ |
|
| Isorhamnetin | leaves, 70% EtOH | HPLC-MS detection | Anti-inflammatory [ |
|
| Hyperin 6”-gallate | leaves, 70% EtOH | HPLC-MS detection | Antioxidant [ |
|
| Quercetin- | leaves, 70% EtOH | HPLC-MS detection | Antioxidant [ |
|
| Isorhamnetin-3- | leaves, 70% EtOH | HPLC-MS detection | Antioxidant [ |
|
| ||||
|
| Amentoflavone | leaves, 70% EtOH | HPLC-MS detection | Anti-inflammatory [ |
|
| ||||
|
| Catechin | leaves, 70% EtOH | HPLC-MS detection | Anti-inflammatory [ |
|
| Epicatechin | leaves, 70% EtOH | HPLC-MS detection | Anti-inflammatory [ |
|
| ||||
|
| Phytol | leaves, 70% EtOH, hexane fraction | GC-MS detection [ | Anti-inflammatory [ |
|
| Squalene | leaves, 70% EtOH, hexane fraction | GC-MS detection [ | Antioxidant [ |
|
| β-Sitosterol | leaves, 70% EtOH, hexane fraction | GC-MS detection [ | Anti-inflammatory [ |
|
| β-Carotene | leaves, acetone | HPLC-MS detection | Anti-inflammatory [ |
|
| (all- | leaves, acetone | HPLC-MS detection | Anti-inflammatory [ |
|
| (all- | leaves, acetone | HPLC-MS detection | Anti-inflammatory [ |
|
| (all- | leaves, acetone | HPLC-MS detection | Anti-inflammatory [ |
|
| (13 | leaves, acetone | HPLC-MS detection | Antioxidant [ |
|
| (all- | leaves, acetone | HPLC-MS detection | N.A. |
|
| ||||
|
| leaves, 70% EtOH, hexane fraction | GC-MS detection [ | Antioxidant [ | |
|
| ||||
|
| Ethyl palmitate | leaves, 70% EtOH, hexane fraction | GC-MS detection [ | Anti-inflammatory [ |
|
| ||||
|
| Pheophorbide | leaves, 90% EtOH | Isolation [ | Anti-inflammatory [ |
* Biological activities concern anti-inflammatory, antioxidant, and healing activity described in previous articles using the isolated components obtained from F. chica or other plants. N.A., not available.
Figure 3Terpenes (32–40), tocochromanol (41), fatty acid (42), and alkaloid (43) of F. chica.
Pharmacological properties of extracts of Fridericia chica.
| Authors | Type of Study | Action | Etiological Agent | Plant Material/Part | Treatment |
|---|---|---|---|---|---|
| [ | In vitro study | Antifungal and antiprotozoal | Trichophyton mentagrophytes (fungus) and | Ethanolic extract of leaves | 4 mg/mL (trypanocide); 3.125 mg/mL (fungicide) |
| [ | In vitro study | Antiprotozoal | Hexanic leaf extract | 37.2 µg/mL ( | |
| [ | In vitro and in vivo study | Antiprotozoal and healing | Ethanolic extract of leaves and fractions | Leishmanicidal effect: 60–155.9 μg/mL; healing effect: 10 mg/g | |
| [ | In vitro study | Antiprotozoal |
| Hydroethanolic extract of leaves and fractions | 24.8 μg/mL–213 μg/mL (hydroethanolic extract); 2.3 μg/mL–10 μg/mL (feoforbide-a) |
| [ | In vivo Study | Antimicrobial | Hydroethanolic extract of leaves | 12.5 μg/mL ( | |
| [ | In vitro study | Antimicrobial | Hydroalcoholic extract | 250 μg gallic acid equivalent (GAE)/mL–MIC; 1000 μg GAE/mL–MBC | |
| [ | In vitro study | Antimicrobial | Dichloromethane extract of leaves | 0.007–0.03 mg/mL | |
| [ | In vitro study | Antiviral | aMPV cepa SHS/669/03 | Ethanolic extract of leaves | 2.5 μg/mL |
| [ | In vitro study | Antiviral | Human Herpes Virus type 1 (HHV-1); murine Encephalomyocarditis virus (EMCV); Vaccinia Virus strain Western Reserve (VACV-WR) | Ethanolic extract of leaves | EC50: 245.7 μg/mL (HHV-1); 86.3 μg/mL (VACV-WR) |
| [ | In vivo study | Antitumor | Solid Ehrlich tumor | Ethanolic extract and aqueous extract of leaves | 30 mg/kg body weight (10 days of oral treatment) |
| [ | In vivo study | Antitumor | 7,12-dimethyl injection-induced breast cancer-1,2-benzanthracene (DMBA) | Hydroalcoholic extract of leaves | Oral administration for 16 weeks: extract at a dose of 300 mg/kg; 7,12-dimethyl-1,2-benzanthracene (DMBA) associated with vincristine 250 µg /mL |
| [ | In vitro study | Antitumor and fibroblast proliferation | Human tumor cell lines: MCF-7 (breast), | Crude leaf extracts (without and with enzyme treatment) | 0.25; 2.5 and 25 μg/mL without enzymatic treatment (fibroblast proliferation); 7.4 and 8.7 μg/mL with enzymatic treatment (cytostatic effect for UACC-62–melanoma lineage) |
| [ | Survey of use by health professionals | Anti-inflammatory | Oral diseases | Leaves | Tea (no dose determined) |
| [ | In vivo study | Analgesic and anti-inflammatory | Osteoarthritis induced by sodium monoiodoacetate | Hydroalcoholic extract of leaves | Oral administration s. i.d. for 25 days: 50 mg/kg, 150 mg/kg, 450 mg/kg |
| [ | Survey of studies with herbal medicines | Anti-acne | Does not apply | Not mentioned | Not informed |
| [ | Survey of traditional use | Treatment of skin irritation and healing | Measles and smallpox | Leaves | Infusion and bath (measles and smallpox); leaves macerated and applied to the affected area (lesions) |
| [ | Review | Treatment of tuberculosis-related symptoms | Mycobacterium tuberculosis | Not specified | Not specified |
| [ | Survey of traditional use | Anemia and weakness | Does not apply | Leaves | Not specified |
| [ | In vivo study | Antihypertensive | Does not apply | Hydroalcoholic extract of leaves | Oral administration of the extract at doses of 100 mg/kg; 250 mg/ kg and 500 mg/kg |
| [ | Survey of traditional use | (1) Anemia, weakness, restoration facial color in malaria patients; (2) ovarian cysts, cystitis, hepatitis, liver, diarrhea; (3) flu, cough, anemia; (4) aids getting pregnant, ulcers, (5) vaginal itching | Does not apply | Leaves | (1) maceration or tea; (2) tea or infusion; (3) syrup; (4) bottled; (5) bath. No dose determined |
| [ | Ex vivo study | Photoprotection | Does not apply | Various parts | Topical application of nonionic cream with 2.5% ethylacetate fraction and 2.5% hexane fraction |
| [ | In vitro study | Photosensitization | MCF-7 cells of human breast adenocarcinoma | Extract nanoemulsion produced from aerial parts | CC50: 1.3 μg ACE/mL |
| [ | In vitro study | Anti-hepatoxic | Does not apply | Leaves | 0.25–1.25 mg/mL |
| [ | In vivo study | Anti-hepatoxic | Carbon tetrachloride | Ethanolic extract of leaves | 300, 500 and 600 mg/kg |
| [ | In vitro study | Antioxidant | Free Radical DPPH (1,1-diphenyl-2-picrylidazyl | Ethanolic extract of leaves and fractions | 5, 10, 25, 50, 125 and 250 µg/mLin ethanol |
| [ | In vitro study | Antioxidant | Free Radical DPPH (1,1-diphenyl-2-picrylidazyl | Methanolic extract of leaves | 0.25; 2.5; 25 and 250 μg/mL |